These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells. Mittag D; Varese N; Scholzen A; Mansell A; Barker G; Rice G; Rolland JM; O'Hehir RE Eur J Immunol; 2013 Mar; 43(3):723-33. PubMed ID: 23238878 [TBL] [Abstract][Full Text] [Related]
5. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
7. [The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases]. Asher I; Mahlab-Guri K; Sthoeger Z Harefuah; 2013 Sep; 152(9):529-33, 564, 563. PubMed ID: 24364093 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy. Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071 [TBL] [Abstract][Full Text] [Related]
9. [Reappraisal of inhalant allergens available for allergy practice in Japan. A need to increase allergen extracts available for immunotherapy]. Nagaya H Arerugi; 1991 Jan; 40(1):60-4. PubMed ID: 2029221 [TBL] [Abstract][Full Text] [Related]
10. Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy. Gueguen C; Bouley J; Moussu H; Luce S; Duchateau M; Chamot-Rooke J; Pallardy M; Lombardi V; Nony E; Baron-Bodo V; Mascarell L; Moingeon P J Allergy Clin Immunol; 2016 Feb; 137(2):545-58. PubMed ID: 26522402 [TBL] [Abstract][Full Text] [Related]
11. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen. Rolinck-Werninghaus C; Kopp M; Liebke C; Lange J; Wahn U; Niggemann B Int Arch Allergy Immunol; 2005 Feb; 136(2):134-41. PubMed ID: 15650310 [TBL] [Abstract][Full Text] [Related]
12. Does allergen immunotherapy alter the natural course of allergic disorders? Yang X Drugs; 2001; 61(3):365-74. PubMed ID: 11293647 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of CD154+ T cells following ex vivo allergen stimulation illustrates distinct T cell responses to seasonal and perennial allergens in allergic and non-allergic individuals. Smith KA; Gray NJ; Saleh F; Cheek E; Frew AJ; Kern F; Tarzi MD BMC Immunol; 2013 Nov; 14():49. PubMed ID: 24188324 [TBL] [Abstract][Full Text] [Related]
14. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy. Moitra S; Datta A; Mondal S; Hazra I; Faruk SMO; Das PK; Basu AK; Tripathi SK; Chaudhuri S Int Immunopharmacol; 2017 Jun; 47():9-19. PubMed ID: 28349869 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle based-immunotherapy against allergy. Gamazo C; Gastaminza G; Ferrer M; Sanz ML; Irache JM Immunotherapy; 2014; 6(7):885-97. PubMed ID: 25290419 [TBL] [Abstract][Full Text] [Related]
16. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Czarnecka-Operacz M; Jenerowicz D; Silny W Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104 [TBL] [Abstract][Full Text] [Related]
17. Effects of sublingual immunotherapy on allergic inflammation. Incorvaia C; Frati F; Puccinelli P; Marcucci F; Di Cara G; Sensi L; Scurati S; Yacoub MR; Moingeon P Inflamm Allergy Drug Targets; 2008 Sep; 7(3):167-72. PubMed ID: 18782023 [TBL] [Abstract][Full Text] [Related]
18. T regulatory cells and their counterparts: masters of immune regulation. Ozdemir C; Akdis M; Akdis CA Clin Exp Allergy; 2009 May; 39(5):626-39. PubMed ID: 19422105 [TBL] [Abstract][Full Text] [Related]
19. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance. Moingeon P; Mascarell L Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498 [TBL] [Abstract][Full Text] [Related]
20. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease. Rolland JM; Prickett S; Gardner LM; O'Hehir RE Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]